| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.034 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |